BCM
MTEM

BlueCrest Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

BlueCrest Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,043
Closed -$157K – 1678
2017
Q4 		$157K Buy
+1,043
New +$131K ﹤0.01% 734

Other funds holding MTEM

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlueCrest Capital Management's MTEM Position: Q1 2018 in Review

BlueCrest Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q1 2018, closing a stake of 1,043 shares — an estimated $157K sold.

BlueCrest Capital Management first reported a position in MTEM in Q4 2017 and held it in 1 quarter. The position peaked at $157K in Q4 2017. 46 funds tracked by Wall St. Rank hold MTEM as of Q1 2018.

  • BlueCrest Capital Management reported no remaining Molecular Templates, Inc. position as of Q1 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 1,043 Molecular Templates, Inc. shares in Q1 2018, an estimated $157K.
  • BlueCrest Capital Management first reported a position in Molecular Templates, Inc. in Q4 2017 and held it in 1 quarter.
  • BlueCrest Capital Management's Molecular Templates, Inc. position peaked at $157K in Q4 2017.
  • 46 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2018.

Based on BlueCrest Capital Management's 13F filing for Q1 2018, filed 15 May 2018.